AngioDynamics, Inc. ANGO
NASDAQ
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 80.92M | 86.61M | 78.42M | 79.43M | 75.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 80.92M | 86.61M | 78.42M | 79.43M | 75.71M |
| Cost of Revenue | 34.08M | 39.83M | 36.94M | 34.65M | 33.85M |
| Gross Profit | 46.84M | 46.77M | 41.48M | 44.78M | 41.86M |
| SG&A Expenses | 42.61M | 41.53M | 38.31M | 37.00M | 40.78M |
| Depreciation & Amortization | 2.73M | 2.72M | 2.67M | 2.64M | 2.65M |
| Other Operating Expenses | -- | 138.00K | -- | -- | -- |
| Total Operating Expenses | 87.24M | 92.26M | 84.85M | 81.92M | 83.61M |
| Operating Income | -6.32M | -5.65M | -6.43M | -2.49M | -7.90M |
| Income Before Tax | -7.30M | -11.04M | -8.07M | -6.36M | -10.84M |
| Income Tax Expenses | -199.00K | 370.00K | 12.00K | -5.00K | 65.00K |
| Earnings from Continuing Operations | -7.10M | -11.41M | -8.08M | -6.35M | -10.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.10M | -11.41M | -8.08M | -6.35M | -10.90M |
| EBIT | -6.32M | -5.65M | -6.43M | -2.49M | -7.90M |
| EBITDA | -823.00K | -353.00K | -838.00K | 3.26M | -1.95M |
| EPS Basic | -0.17 | -0.27 | -0.19 | -0.15 | -0.26 |
| Normalized Basic EPS | -0.09 | -0.10 | -0.02 | -0.04 | -0.12 |
| EPS Diluted | -0.17 | -0.27 | -0.19 | -0.15 | -0.26 |
| Normalized Diluted EPS | -0.09 | -0.10 | -0.02 | -0.04 | -0.12 |
| Average Basic Shares Outstanding | 42.02M | 41.70M | 41.60M | 41.54M | 41.17M |
| Average Diluted Shares Outstanding | 42.02M | 41.70M | 41.60M | 41.54M | 41.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |